peptide science tirzepatide 10mg — GLP-1/GIP Dual-Agonist Research Shop Tirzepatide Research Compound (20mg)
Description
Your healthcare provider may continue increasing the dose by 2.5 mg every 4 weeks until reaching the target therapeutic dose (commonly 1015 mg weekly)
It affects appetite, fullness, digestion, and metabolic signaling
They are also not universal
Incretin peptides like GLP-1 and GIP occur naturally in the human body as signaling molecules
This article will help you through this change
